Skip to main content
Alphanox Co.,Ltd. logo

Alphanox Co.,Ltd. — Investor Relations & Filings

Ticker · 043100 ISIN · KR7043100007 KO Manufacturing
Open in API
Filings indexed 364 across all filing types
Latest filing 2025-07-14 Major Shareholding Noti…
Country KR South Korea
Listing KO 043100

About Alphanox Co.,Ltd.

https://alphanox.co.kr/en/

Alphanox Co.,Ltd., formerly known as Solco Biomedical, is a global medical and healthcare group established in 1974. The company specializes in the development, manufacturing, and sale of advanced medical devices and health-promoting products. Its primary product lines include surgical instruments, orthopedic implants with a strong focus on spinal applications, and in-vitro diagnostic devices. In addition to its core medical offerings, Alphanox also produces healthcare products such as functional water and other health-promoting devices. The company is committed to improving quality of life through extensive research and development grounded in medical engineering and clinical results.

Recent filings

Filing Released Lang Actions
최대주주변경을수반하는주식양수도계약체결
Major Shareholding Notification Classification · 100% confidence The document is a regulatory filing regarding a change in the company's largest shareholder due to a stock purchase agreement. This type of disclosure is a standard corporate event announcement in South Korean financial markets (DART system). Since it involves a change in control/ownership structure and does not fit into specific categories like 'Director's Dealing' (which is for individual insider trades) or 'Major Shareholding Notification' (which is usually filed by the investor), it falls under the 'Regulatory Filings' category as a general corporate announcement.
2025-07-14 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details changes in share ownership, specifically the dissolution of a special relationship between the reporter and joint holders. This falls under the category of Major Shareholding Notification (MRQ).
2025-06-02 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. This document tracks changes in share ownership that cross specific reporting thresholds. In the provided classification schema, this falls under 'Major Shareholding Notification' (MRQ), as it details the ownership status and changes in shareholding for the reporting entity and their special relations.
2025-06-02 Korean
주주총회소집결의 (임시주주총회)
AGM Information Classification · 98% confidence The document is an official notice of an Extraordinary General Meeting (EGM) for the company 'Alphanox'. It details the date, time, location, and the agenda items (specifically, amendments to the articles of incorporation and business purpose changes). This type of document is a formal proxy solicitation or notice of meeting sent to shareholders to inform them of upcoming voting matters, which falls under the Proxy Solicitation & Information Statement category.
2025-05-27 Korean
주주명부폐쇄기간또는기준일설정
Notice of Dividend Amount Classification · 95% confidence The document is a formal regulatory announcement regarding the setting of a record date for an upcoming Extraordinary General Meeting (EGM). It is a short, standardized regulatory filing (DART/KRX format) that does not contain the full proxy materials or the meeting presentation itself, but rather serves as a notice of corporate action. Since it relates to shareholder meeting logistics and does not fit into specific categories like 'Proxy Solicitation' (which would contain the full agenda and voting materials) or 'AGM-R', it is best classified as a general regulatory filing.
2025-05-27 Korean
전환사채(해외전환사채포함)발행후만기전사채취득
Capital/Financing Update Classification · 100% confidence The document is a regulatory filing from a Korean company (Alphanox) detailing the acquisition of its own convertible bonds before maturity due to a put option exercise. This falls under capital structure changes and financing updates. Since it specifically details the repurchase/acquisition of debt instruments (convertible bonds), it fits best under the 'Capital/Financing Update' category.
2025-05-26 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.